PREVENTION OF THE TRANSIENT ADVERSE-EFFECTS OF A GONADOTROPIN-RELEASING HORMONE ANALOG (BUSERELIN) IN METASTATIC PROSTATIC-CARCINOMA BY ADMINISTRATION OF AN ANTIANDROGEN (NILUTAMIDE)

被引：140

作者：

KUHN, JM

BILLEBAUD, T

NAVRATIL, H

MOULONGUET, A

FIET, J

GRISE, P

LOUIS, JF

COSTA, P

HUSSON, JM

DAHAN, R

BERTAGNA, C

EDELSTEIN, R

机构：

[1] HOP MONTFERMEIL, DEPT UROL, MONTFERMEIL, FRANCE

[2] INST ROUSSEL UCLAF, DEPT MED, ROMAINVILLE, FRANCE

[3] CHR NIMES, DEPT UROL, NIMES, FRANCE

[4] HOP BICHAT, DEPT UROL, F-75877 PARIS 18, FRANCE

[5] CHR ROUEN, DEPT ENDOCRINOL, ROUEN, FRANCE

[6] CHR ROUEN, DEPT UROL, ROUEN, FRANCE

[7] HOP ST LOUIS, BIOCHEM LAB, F-75475 PARIS 10, FRANCE

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 321卷 / 07期

关键词：

D O I：

10.1056/NEJM198908173210701

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 418

页数：6

共 35 条

[11] CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF ZOLADEX (ICI-118,630-AN LH-RH ANALOG) TO PATIENTS WITH ADVANCED PROSTATIC-CANCER
DONNELLY, RJ
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B) : 1375 - 1375
[12] PRELIMINARY-RESULTS ON THE CLINICAL EFFICACY AND SAFETY OF ANDROGEN INHIBITION BY AN LHRH AGONIST ALONE OR COMBINED WITH AN ANTI-ANDROGEN IN THE TREATMENT OF PROSTATIC-CARCINOMA
FAURE, N
LEMAY, A
LAROCHE, B
ROBERT, G
PLANTE, R
JEAN, C
THABET, M
ROY, R
FAZEKAS, ATA
[J]. PROSTATE, 1983, 4 (06) : 601 - 624
[13] GARNICK MB, 1984, NEW ENGL J MED, V311, P1281
[14] GELLER J, 1985, SEMIN ONCOL, V12, P28
[15] AN EVALUATION OF PROSTATE SPECIFIC ANTIGEN IN PROSTATIC-CANCER
GUINAN, P
BHATTI, R
RAY, P
[J]. JOURNAL OF UROLOGY, 1987, 137 (04) : 686 - 689
[16] TREATMENT OF PROSTATIC-CANCER WITH A GONADOTROPIN-RELEASING HORMONE AGONIST ANALOG - ACUTE AND LONG-TERM EFFECTS ON ENDOCRINE FUNCTIONS OF TESTIS TISSUE
HUHTANIEMI, I
NIKULA, H
RANNIKKO, S
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (04) : 698 - 704
[17] KAHAN A, 1984, LANCET, V1, P971
[18] KLIGN JGM, 1985, LANCET, V2, P493
[19] OBJECTIVE RESPONSE AND DISEASE OUTCOME IN 59 PATIENTS WITH STAGE-D2 PROSTATIC-CANCER TREATED WITH EITHER BUSERELIN OR ORCHIECTOMY - DISEASE AGGRESSIVENESS AND ITS ASSOCIATION WITH RESPONSE AND OUTCOME
KOUTSILIERIS, M
FAURE, N
TOLIS, G
LAROCHE, B
ROBERT, G
ACKMAN, CFD
[J]. UROLOGY, 1986, 27 (03) : 221 - 228
[20] FLUTAMIDE ELIMINATES THE RISK OF DISEASE FLARE IN PROSTATIC-CANCER PATIENTS TREATED WITH A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST
LABRIE, F
DUPONT, A
BELANGER, A
LACHANCE, R
[J]. JOURNAL OF UROLOGY, 1987, 138 (04) : 804 - 806

← 1 2 3 4 →